NCT00644228

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2008-07-28Est. Completion: 2015-11-05

Enrollment target: 525 participants

Locations

Providence Alaska Medical Center, Anchorage, Alaska, United States
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
Banner University Medical Center - Tucson, Tucson, Arizona, United States
University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States
PCR Oncology, Arroyo Grande, California, United States
Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
Mills-Peninsula Medical Center, Burlingame, California, United States
Kaiser Permanente-Fremont, Fremont, California, United States
Kaiser Permanente-Fresno, Fresno, California, United States
Saint Jude Medical Center, Fullerton, California, United States
Marin General Hospital, Greenbrae, California, United States

Multiple Myeloma

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marro…

Birmingham, United StatesEst. completion Dec 2027

Multiple Myeloma

Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myel…

Jupiter, United StatesEst. completion Oct 18, 2030

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.